Pfizer Takes 230K-SF at San Diego Life Science Campus
The lease is more than double the size of similar deals in the area last year.
Pfizer Oncology has signed a 15-year, 230,000-square foot lease at the Torrey View life science campus nearing completion in San Diego by Breakthrough Properties, which is a joint venture between Tishman Speyer and biotechnology investment firm Bellco Capital.
The ten-acre campus is now fully pre-leased and the company claims that 89% of the three-building Torrey View is now secured by long-term investment grade credit, with the balance leased to biotechnology firms.
The Pfizer lease is more than double the size of any life-science deal in the San Diego area in 2023, when the largest single tenant was Acon taking 97,162 square feet, Bloomberg said, citing CBRE figures.
Breakthrough also announced a new collaboration between its StudioLabs platform and Pfizer Ignite to provide an R&D service connecting companies to Pfizer’s suite of research, development and manufacturing services as well as providing input from an advisory network.
Breakthrough clients will gain access to Pfizer’s resources, scale, and expertise and the company says there may also be opportunities for clients to collaborate with Pfizer’s CDMO, CentreOne, and its broader partnering models, such as Pfizer Ventures.